In 2016, Saini et al. used a human iPSC model of AMD to demonstrate that nicotinamide altered disease-related phenotypes (ARMS2/HTRA1) by inhibiting drusen proteins and inflammatory and complement factors [13]. The gene discussed is HTRA1; the disease is age-related macular degeneration.